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NEUROVASCULAR CHANGES IN THE OA JOINT
D.A. Walsh. Univ. of Nottingham, Nottingham, United Kingdom
Purpose: To describe current knowledge leading to a better under-
standing of OA pain and potential therapeutic targets for symptom and
structural modiﬁcation.
Methods: Narrative review.
Results: Pain originates from the OA joint, mediated by primary noci-
ceptive neurons that have been localised to the majority of articular
structures. Fine, myelinated Ad ﬁbres are localised to joint capsule,
periosteum and muscles, whereas unmyelinated C ﬁbres are most
abundant with synovium and subchondral bone marrow spaces.
Unmyelinated afferents predominantly accompany blood vessels, and
serve both sensory (pain) and efferent (control of vascular tone, per-
meability and proliferation) functions. During OA, sensory nerves
change in their distribution, growing with blood vessels into articular
cartilage and the inner two thirds of knee menisci. Furthermore,
peripheral sensory nerve function is augmented (peripheral sensitisa-
tion), accompanied by changes in ion channel phosphorylation, neu-
romodulator and neurotransmitter expression. Key drivers of
peripheral sensitisation offer potential as novel therapeutic targets for
OA pain, including nerve growth factor, calcitonin gene-related peptide,
and pro-inﬂammatory cytokines. Neuronal and vascular functions are
tightly integrated, with factors originally recognised in pain processing
pathways also modulating vascular function, and others, such as vas-
cular endothelial growth factor, now known to also play important roles
in neuronal growth and sensitisation. The joint vasculature is key to
maintaining articular health, by facilitating metabolic homeostasis,
contributing to tissue repair and new bone formation. Inappropriate or
inadequate vascular responses might lead to relative hypoxia and
acidosis, loss of osteochondral integrity and persistent inﬂammation;
each of which can exacerbate OA pain.
Conclusions: Targeting the neurovascular plasticity that is observed in
OA joints might not only afford short term pain relief, but also modify
symptomatically relevant structural changes and therefore afford sus-
tained reductions in the burden of OA.
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ROLE OF ZN2þ IMPORT AND THE ZN2þ/ZIP8/MTF1 AXIS ON OA
J.-S. Chun. Gwangju Inst. of Sci. and Technology (GIST), Gwangju, Republic
of Korea
Osteoarthritis (OA), primarily characterized by cartilage degeneration,
is caused by an imbalance between anabolic and catabolic factors. Here,
we investigated the role of zinc (Zn2þ) homeostasis, Zn2þ transporters,
and Zn2þ-dependent transcription factors in OA pathogenesis. Among
Zn2þ transporters, the Zn2þ importer ZIP8 was speciﬁcally upregu-
lated in OA cartilage of humans andmice, resulting in increased levels of
intracellular Zn2þ in chondrocytes. ZIP8-mediated Zn2þ inﬂux upre-
gulated the expression of matrix-degrading enzymes (MMP3, MMP9,
MMP12, MMP13, and ADAMTS5) in chondrocytes. Ectopic expression of
ZIP8 in mouse cartilage tissue caused OA cartilage destruction, whereas
Zip8 knockout suppressed surgically induced OA pathogenesis, with
concomitant modulation of Zn2þ inﬂux and matrix-degrading
enzymes. Furthermore, MTF1 was identiﬁed as an essential tran-
scription factor in mediating Zn2þ/ZIP8-induced catabolic factor
expression, and genetic modulation of Mtf1 in mice altered OA patho-
genesis. We propose that the zincZIP8MTF1 axis is an essential
catabolic regulator of OA pathogenesis.
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THE CIRCADIAN CLOCK IN CARTILAGE HOMEOSTASIS
M. Dudek y, N. Gossan y, N. Yang y, D. Pathiranage y, H.-J. Im z, D. Jin y,
X. Li z, R. Boot-Handford y, Q.-J. Meng y. yUniv. of Manchester,
Manchester, United Kingdom; zRush Univ., Chicago, IL, USA
Purpose: Osteoarthritis (OA) is the most common joint disorder for
which age is a major risk factor. We have previously identiﬁed auton-
omous circadian clocks in chondrocytes that become dysregulated with
age and in an injury model of OA in mouse. More recently, we have
shown that environmental disruption of the circadian rhythm in mice
predisposes to OA-like cartilage degeneration in the knee. The objec-
tives were to characterize the circadian clock and their tissue-speciﬁc
targets in normal, aged and diseased cartilage tissues, and to providegenetic evidence and mechanistic insights linking the chondrocyte
circadian clock to cartilage pathologies.
Methods: Cartilage explants were obtained from aged and young mice
with the clock reporter PER2::luc, and real-time bioluminescence
recordings were used to characterize the properties of the clock. Time-
series microarrays and RNAseq were performed on mouse cartilage
tissues to identify rhythmic genes. Experimental OA was induced in
mice by destabilization of the medial meniscus (DMM). A Col2a1-Cre
driven conditional Bmal1 knockout mouse was made to evaluate the
role of chondrocyte clock in cartilage health and disease.
Results: Autonomous circadian clocks in mouse cartilage tissue and
human chondrocytes were identiﬁed, which can be entrained by sys-
temic factors such as body temperature rhythms. The circadian and
diurnal transcriptomes in mouse cartilage revealed a large number of
rhythmic genes involved in cartilage homeostasis and chondrocyte
survival. Several clock genes were disrupted in the early stages of car-
tilage degeneration in the DMM mouse model of OA, as well as in
human OA samples. Further, the conditional chondrocyte-Bmal1
knockout mouse model caused no developmental abnormalities in the
articular cartilage although signiﬁcant pathology became apparent in
the adult articular cartilage. RNAseq revealed global changes in gene
expression that favours a more catabolic state of the Bmal1 KO
chondrocytes.
Conclusions: These results reveal an autonomous circadian clock in
chondrocytes that is implicated in key aspects of cartilage tissue
homeostasis and chondrocyte health. We envisage a scenario where
chronic circadian disruption or misalignment (e.g. during aging) may
compromise cartilage tissue homeostasis and increase susceptibility to
joint damage or disease. Further investigations may lead to novel tar-
geting strategies for joint diseases, including timed drug administration
(chronotherapy), or the use of circadian clock-acting compounds.
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HOW CAN DISTURBANCES OF THE NERVOUS SYSTEMS TRANSLATE IN
OA PHENOTYPES?
F. Berenbaum. Univ. P&M Curie Paris 06, INSERM UMRS_938, APHP Saint-
Antoine, Paris, France
Osteoarthritis has long been considered as a joint disease inﬂuenced by
local factors only (such as overload, joint trauma or anatomical
deformities) which would trigger cartilage, subchondral bone and
synovial cells activation leading to the release of degradative mediators
eventually destroying the matrix. More recently, observational and
interventional experimental studies have shown that a systemic low-
grade inﬂammation component could play an additional role, at least in
a subgroup of OA patients suffering from metabolic diseases like obe-
sity, diabetes mellitus, lipid abnormalities or hypertension. Because of
the recent knowledge about close connections between inﬂammation,
metabolic diseases and the brain, the inﬂuence of nervous system
pathways on initiation and/or progression of OA could be considered,
too. In this lecture, these potential pathways involved in communica-
tions between OA joints and the nervous system will be presented. The
role of the circadian rhythms and of the autonomic nervous system on
the pathophysiology of OA will be particularly developed.
Such an integrative vision of the OA process is changing our paradigm
by including OA in the list of the metabolic diseases that could be
inﬂuenced by the brain. If conﬁrmed, this hypothesis could be a
breakthrough for treating OA, by seeking new targets modulating these
pathways. A cross-cutting approach of the pathophysiology of the dis-
ease is now inevitable for a step-forward in the treatment approach of
OA in the future.
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“BONY” PHENOTYPE: WORTHWHILE AS THERAPEUTIC TARGET?
J.H. Tobias. Univ. of Bristol, Sch. of Clinical Sci., Bristol, United Kingdom
Background: Epidemiological studies suggest a positive relationship
exists between bone mineral density (BMD) and incident osteoarthritis
(OA), but the relationship with OA progression is less certain. To
establish whether increased BMD is linked to a causal pathway for OA,
we examined OA phenotypes in a unique cohort of individuals with
high bone mass (HBM), in whom BMD is assumed to be elevated due to
genetically increased rates of bone formation.
